Table of Contents

1 Report Overview

• 1.1 Study Scope
• 1.2 Key Market Segments
• 1.3 Players Covered
• 1.4 Market Analysis by Type
  • 1.4.1 Global Etravirine Market Size Growth Rate by Type (2014-2025)
  • 1.4.2 25 mg Tablets
  • 1.4.3 100 mg Tablets
  • 1.4.4 200 mg Tablets
• 1.5 Market by Application
  • 1.5.1 Global Etravirine Market Share by Application (2014-2025)
  • 1.5.2 Adults
  • 1.5.3 Pediatric patients
• 1.6 Study Objectives
• 1.7 Years Considered

2 Global Growth Trends

• 2.1 Etravirine Market Size
• 2.2 Etravirine Growth Trends by Regions
  • 2.2.1 Etravirine Market Size by Regions (2014-2025)
  • 2.2.2 Etravirine Market Share by Regions (2014-2019)
• 2.3 Industry Trends
  • 2.3.1 Market Top Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Opportunities

3 Market Share by Key Players

• 3.1 Etravirine Market Size by Manufacturers
  • 3.1.1 Global Etravirine Revenue by Manufacturers (2014-2019)
  • 3.1.2 Global Etravirine Revenue Market Share by Manufacturers (2014-2019)
  • 3.1.3 Global Etravirine Market Concentration Ratio (CR5 and HHI)
• 3.2 Etravirine Key Players Head office and Area Served
• 3.3 Key Players Etravirine Product/Solution/Service
• 3.4 Date of Enter into Etravirine Market
• 3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application

• 4.1 Global Etravirine Market Size by Type (2014-2019)
• 4.2 Global Etravirine Market Size by Application (2014-2019)

5 United States

• 5.1 United States Etravirine Market Size (2014-2019)
• 5.2 Etravirine Key Players in United States
• 5.3 United States Etravirine Market Size by Type
• 5.4 United States Etravirine Market Size by Application

6 Europe

• 6.1 Europe Etravirine Market Size (2014-2019)
• 6.2 Etravirine Key Players in Europe
• 6.3 Europe Etravirine Market Size by Type
• 6.4 Europe Etravirine Market Size by Application

7 China

• 7.1 China Etravirine Market Size (2014-2019)
• 7.2 Etravirine Key Players in China
• 7.3 China Etravirine Market Size by Type
• 7.4 China Etravirine Market Size by Application

8 Japan

• 8.1 Japan Etravirine Market Size (2014-2019)
• 8.2 Etravirine Key Players in Japan
• 8.3 Japan Etravirine Market Size by Type
• 8.4 Japan Etravirine Market Size by Application

9 Southeast Asia

• 9.1 Southeast Asia Etravirine Market Size (2014-2019)
• 9.2 Etravirine Key Players in Southeast Asia
• 9.3 Southeast Asia Etravirine Market Size by Type
• 9.4 Southeast Asia Etravirine Market Size by Application

10 India

• 10.1 India Etravirine Market Size (2014-2019)
• 10.2 Etravirine Key Players in India
• 10.3 India Etravirine Market Size by Type
• 10.4 India Etravirine Market Size by Application

11 Central & South America

• 11.1 Central & South America Etravirine Market Size (2014-2019)
• 11.2 Etravirine Key Players in Central & South America
• 11.3 Central & South America Etravirine Market Size by Type
• 11.4 Central & South America Etravirine Market Size by Application

12 International Players Profiles

• 12.1 Janssen Therapeutics
  • 12.1.1 Janssen Therapeutics Company Details
  • 12.1.2 Company Description and Business Overview
  • 12.1.3 Etravirine Introduction
  • 12.1.4 Janssen Therapeutics Revenue in Etravirine Business (2014-2019)
  • 12.1.5 Janssen Therapeutics Recent Development

13 Market Forecast 2019-2025

• 13.1 Market Size Forecast by Regions
• 13.2 United States
• 13.3 Europe
• 13.4 China
• 13.5 Japan
• 13.6 Southeast Asia
• 13.7 India
• 13.8 Central & South America
• 13.9 Market Size Forecast by Product (2019-2025)
• 13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix

• 15.1 Research Methodology
  • 15.1.1 Methodology/Research Approach
    • 15.1.1.1 Research Programs/Design
    • 15.1.1.2 Market Size Estimation
    • 12.1.1.3 Market Breakdown and Data Triangulation
  • 15.1.2 Data Source
    • 15.1.2.1 Secondary Sources
    • 15.1.2.2 Primary Sources
• 15.2 Disclaimer

Etravirine (ETR, brand name Intelence, formerly known as TMC125) is a drug used for the treatment of HIV. Etravirine is a non-nucleoside reverse transcriptase inhibitor (NNRTI). Unlike the currently available agents in the class, resistance to other NNRTIs does not seem to confer resistance to etravirine.
In 2018, the global Etravirine market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Etravirine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Etravirine development in United States, Europe and China.

The key players covered in this study
Janssen Therapeutics
...

Market segment by Type, the product can be split into
25 mg Tablets
100 mg Tablets
200 mg Tablets

Market segment by Application, split into
Adults
Pediatric patients

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Etravirine status, future forecast, growth opportunity, key market and key players.
To present the Etravirine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Etravirine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.